• Evertrace
  • Posts
  • Launches by Evertrace - Week 48

Launches by Evertrace - Week 48

Preview the power of AI-powered founder detection

Welcome to Launches by Evertrace!

Get a sneak peek of what our platform can do with this data-driven newsletter, crafted to help investors discover new opportunities. Enjoy this week’s edition - we’re excited to have you with us!

Heads up! The data in the Launches by Evertrace newsletter are intentionally delayed to give our customers a strategic advantage. Access real-time signals by requesting a free trial.

New Incorporations

Evertrace flags thousands of fresh company incorporations each month. Here’s a snapshot of the new entities found in local trade registries:

contebia.ia GmbH
Konstanz, Germany· 21 November 2025

Description: The development, operation, and distribution of software solutions and digital platforms, particularly in the field of artificial intelligence and automation of business processes, as well as the provision of related consulting and service activities without taking on regulated activities

Nordic Energy Core AB
Sweden· 20 November 2025

Founder: Ivan Cokor

Description: Electrical installations, service and maintenance of electrical systems, design, installation and operation of UPS systems, generators, backup power and battery storage, automation, control and regulation systems

Potential Sciences UK LTD
London, United Kingdom· 19 November 2025

Founder: Hatem Helal

Description: Engineering design activities for industrial process and production, research and experimental development on biotechnology

Newly published patents

Evertrace identifies newly published patents with breakthrough potential. Explore recent standouts:

3D Tumor Model Bioprinting
San Sebastián, Spain
Inventor: Clara García Astrain

Description: Process for preparing a three-dimensional tumor model having a core-shell structure using bioprinting techniques leading to tumor models capable of better reproducing the physiopathological complexity of real tumors

Gastric Cancer Classification Kit
Llleida, Spain
Inventor: Robert Montal

Description: Assay for determining the class of gastric adenocarcinoma in a tissue sample using the expression of a gene signature. Specifically, the invention is directed to the utilization of a gene signature in a method to identify and distinguish gastric adenocarcinoma tumors of the "inflamed class"

mRNA Booster
Mainz, Germany
Inventor: Maria José Limeres

Description: An mRNA encoding for an Flt3L protein or a functional fragment thereof for use in enhancing an immune response in a subject.

Get real-time signals and deep intelligence by requesting access to Evertrace.